至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

PD-1 Signaling Promotes Control of Chronic Viral Infection by Restricting Type-I-Interferon-Mediated Tissue Damage

Cell Rep.. 2019; 
Raju S1, Verbaro DJ1, Egawa T2.
Products/Services Used Details Operation
Peptide Synthesis … H2-Db(LCMV gp276-284) tetramer, MBL International, CAT#TB-5009-1. Fetal Bovine Serum,<br> Thermofisher, CAT#10437028. LCMV gp276-284 peptide, <b>Genscript</b>, CAT#RP19983. LCMV<br> gp33-41 peptide, <b>Genscript</b>, CAT#RP20257. Linear Acrylamide, Ambion, CAT#AM9520 … Get A Quote

摘要

Immune responses are essential for pathogen elimination but also cause tissue damage, leading to disease or death. However, it is unclear how the host immune system balances control of infection and protection from the collateral tissue damage. Here, we show that PD-1-mediated restriction of immune responses is essential for durable control of chronic LCMV infection in mice. In contrast to responses in the chronic phase, PD-1 blockade in the subacute phase of infection paradoxically results in viral persistence. This effect is associated with damage to lymphoid architecture and subsequently decreases adaptive immune responses. Moreover, this tissue damage is type I interferon dependent, as sequential blockade o... More

关键词